Nexvet scores tax incentive from Aussie government; Jaguar forms manufacturing pact with Glenmark; Zoetis declares Q4 dividend;

> Nexvet Biopharma ($NVET) announced that it received $3.2 million in cash from the Australian government, as part of the country's Research and Development (R&D) Tax Incentive program. Release

> Jaguar Animal Health ($JAGX) announced it has formed a four-year agreement with Glenmark Pharmaceuticals, which will be the primary manufacturer of crofelemer, the active ingredient in Jaguar's leading drug candidate, Canalevia, to treat diarrhea in dogs. Release

> Zoetis ($ZTS) declared a fourth-quarter dividend of $0.083 per share, payable December 1. Release

> New York-based P&S Market Research released a report estimating that the global animal health industry will maintain a compound annual growth rate of 7% through 2020, growing from $29.5 billion in 2014 to $44.2 billion. Release

> The FDA has issued its final revised Veterinary Feed Directive guidance, along with a list of states that have associated veterinarian-client-patient-relationship requirements. Notice

> GlobalVetLink announced that it has introduced system enhancements to help veterinary clinics comply with the FDA's new Veterinary Feed Directive. Release

> BIO-Europe announced that its 2015 conference in November will include a panel dedicated to animal health for the first time. Release

> Salix Animal Health announced it has recalled one lot of its Good 'n' Fun Beefhide Chicken Sticks because of potential Salmonella contamination. Release

> OC Raw Dog recalled 640 pounds of its Chicken, Fish & Produce Raw Frozen Canine Formulation because of potential Salmonella contamination. Release

> Zoetis has joined with the Association of American Veterinary Medical Colleges to offer $2,000 scholarships to second- and third-year veterinary students. Release

> A case of bovine spongiform encephalopathy, better known as mad cow disease, was discovered on a farm in Wales, marking the first case of the disease there since 2013. Article

> Western Milling announced that it has recalled 50-pound bags of Western Blend horse feed because one of the ingredients, monensin, can be poisonous at some dosages. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…